Oncopeptides AB (publ)
ONPPF · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $107 | $179 | $250 | $383 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $35 | $0 | $35 | $0 |
| Inventory | $6 | $4 | $5 | $5 |
| Other Curr. Assets | $0 | $34 | $0 | $33 |
| Total Curr. Assets | $149 | $217 | $289 | $421 |
| Property Plant & Equip (Net) | $25 | $27 | $29 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $1 | $32 |
| Total NC Assets | $25 | $27 | $30 | $32 |
| Other Assets | $0 | $0 | -$0 | $0 |
| Total Assets | $173 | $244 | $319 | $453 |
| Liabilities | – | – | – | – |
| Payables | $11 | $18 | $12 | $9 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $36 | $33 | $34 | $112 |
| Total Curr. Liab. | $46 | $51 | $46 | $121 |
| LT Debt | $118 | $122 | $117 | $115 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $15 | $17 | $20 | $24 |
| Total NC Liab. | $133 | $139 | $137 | $139 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $179 | $190 | $184 | $260 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $24 |
| Retained Earnings | $0 | $0 | $0 | $0 |
| AOCI | $0 | $0 | $0 | $169 |
| Other Equity | -$6 | $54 | $136 | $0 |
| Total Equity | -$6 | $54 | $136 | $193 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $173 | $244 | $319 | $453 |
| Net Debt | $11 | -$57 | -$133 | -$268 |